Previous close | 16.00 |
Open | 16.50 |
Bid | 16.50 |
Ask | 16.80 |
Strike | 155.00 |
Expiry date | 2023-07-21 |
Day's range | 15.55 - 16.50 |
Contract range | N/A |
Volume | |
Open interest | 277 |
Moderna's CEO Stéphane Bancel faced off with Sen. Bernie Sanders and others of the Senate HELP committee to defend raising the COVID vaccine price for the commercial market.
Moderna (MRNA) closed the most recent trading day at $149.42, moving +0.84% from the previous trading session.
Collaboration will extend the applications of each company’s platform through discovery and development of novel lipid nanoparticles using Generation Bio’s proprietary stealth cell-targeted lipid nanoparticle (ctLNP) delivery system Moderna has acquired an option to license Generation Bio’s ctLNP and closed-ended DNA (ceDNA) technology for two immune cell programs and two liver programs, with an additional option for a third immune cell or liver program Moderna will fund all research and develop